Sökning: WFRF:(Dagenais Gilles R.) >
Effects of Lipid-Lo...
-
Dagenais, Gilles R.Lava Univ, Quebec Heart & Lung Univ Inst, Quebec City, PQ, Canada
(författare)
Effects of Lipid-Lowering and Antihypertensive Treatments in Addition to Healthy Lifestyles in Primary Prevention : An Analysis of the HOPE-3 Trial
- Artikel/kapitelEngelska2018
Förlag, utgivningsår, omfång ...
-
Wiley,2018
-
electronicrdacarrier
Nummerbeteckningar
-
LIBRIS-ID:oai:DiVA.org:uu-372904
-
https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-372904URI
-
https://doi.org/10.1161/JAHA.118.008918DOI
Kompletterande språkuppgifter
-
Språk:engelska
-
Sammanfattning på:engelska
Ingår i deldatabas
Klassifikation
-
Ämneskategori:ref swepub-contenttype
-
Ämneskategori:art swepub-publicationtype
Anmärkningar
-
Background It is not clear whether the effects of lipid-lowering or antihypertensive medications are influenced by adherence to healthy lifestyle factors. We assessed the effects of both drug interventions in subgroups by the number of healthy lifestyle factors in participants in the HOPE-3 (Heart Outcomes Prevention Evaluation) trial.Methods and Results In this primary prevention trial, 4 healthy lifestyle factors (nonsmoking status, physical activity, optimal body weight, and healthy diet) were recorded in 12 521 participants who were at intermediate risk of cardiovascular disease (CVD) and were randomized to rosuvastatin, candesartan/hydrochlorothiazide, their combination, or matched placebos. Median follow-up was 5.6 years. The outcome was a composite of CVD events. Adjusted hazard ratios (HRs) and 95% confidence intervals (CIs) were estimated using Cox regression models. Participants with >= 2 healthy lifestyle factors had a lower rate of CVD compared with those with fewer factors (HR: 0.85; 95% CI, 0.73-1.00). Rosuvastatin reduced CVD events in participants with >= 2 healthy lifestyle factors (HR: 0.74; 95% CI, 0.62-0.90) and in participants with <2 factors (HR: 0.79; 95% CI, 0.61-1.01). Consistent results were observed with combination therapy (>= 2 factors: HR: 0.74; 95% CI, 0.57-0.97; <2 factors: HR: 0.61; 95% CI, 0.43-0.88). Candesartan/hydrochlorothiazide tends to reduce CVD only in participants with <2 healthy lifestyle factors (HR: 0.78; 95% CI, 0.61-1.00).Conclusions Healthy lifestyles are associated with lower CVD. Rosuvastatin alone and combined with candesartan/hydrochlorothiazide is beneficial regardless of healthy lifestyle status; however, the benefit of antihypertensive treatment appears to be limited to patients with less healthy lifestyles.
Ämnesord och genrebeteckningar
Biuppslag (personer, institutioner, konferenser, titlar ...)
-
Jung, HyejungMcMaster Univ, Hamilton Gen Hosp, Populat Hlth Res Inst, Hamilton, ON, Canada
(författare)
-
Lonn, EvaMcMaster Univ, Hamilton Gen Hosp, Populat Hlth Res Inst, Hamilton, ON, Canada
(författare)
-
Bogaty, Peter M.Lava Univ, Quebec Heart & Lung Univ Inst, Quebec City, PQ, Canada
(författare)
-
Dehghan, MahshidMcMaster Univ, Hamilton Gen Hosp, Populat Hlth Res Inst, Hamilton, ON, Canada
(författare)
-
Held, Claes,1956-Uppsala universitet,Uppsala kliniska forskningscentrum (UCR),Kardiologi(Swepub:uu)clahe947
(författare)
-
Avezum, AlvaroUniv Santo Amaro, Dante Pazzanese Inst Cardiol, Sao Paulo, Brazil
(författare)
-
Jansky, PetrUniv Hosp Motol, Prague, Czech Republic
(författare)
-
Keltai, MatyasSemmelweis Univ, Budapest, Hungary
(författare)
-
Leiter, Lawrence A.Univ Toronto, Li Ka Shing Knowledge Inst, St Michaels Hosp, Toronto, ON, Canada;Univ Toronto, Dept Med, Toronto, ON, Canada;Univ Toronto, Dept Nutr Sci, Toronto, ON, Canada
(författare)
-
Lopez-Jaramillo, PatricioUniv Santander UDES, Med Sch, Res Dept, FOSCAL, Bucaramanga, Colombia
(författare)
-
Toff, William D.Univ Leicester, Dept Cardiovasc Sci, Leicester, Leics, England;NIHR Leicester Biomed Res Ctr, Leicester, Leics, England
(författare)
-
Bosch, JackieMcMaster Univ, Hamilton Gen Hosp, Populat Hlth Res Inst, Hamilton, ON, Canada
(författare)
-
Yusuf, SalimMcMaster Univ, Hamilton Gen Hosp, Populat Hlth Res Inst, Hamilton, ON, Canada
(författare)
-
Lava Univ, Quebec Heart & Lung Univ Inst, Quebec City, PQ, CanadaMcMaster Univ, Hamilton Gen Hosp, Populat Hlth Res Inst, Hamilton, ON, Canada
(creator_code:org_t)
Sammanhörande titlar
-
Ingår i:Journal of the American Heart Association: Wiley7:152047-9980
Internetlänk
Hitta via bibliotek
Till lärosätets databas
- Av författaren/redakt...
-
Dagenais, Gilles ...
-
Jung, Hyejung
-
Lonn, Eva
-
Bogaty, Peter M.
-
Dehghan, Mahshid
-
Held, Claes, 195 ...
-
visa fler...
-
Avezum, Alvaro
-
Jansky, Petr
-
Keltai, Matyas
-
Leiter, Lawrence ...
-
Lopez-Jaramillo, ...
-
Toff, William D.
-
Bosch, Jackie
-
Yusuf, Salim
-
visa färre...
- Om ämnet
-
- MEDICIN OCH HÄLSOVETENSKAP
-
MEDICIN OCH HÄLS ...
-
och Klinisk medicin
-
och Kardiologi
- Artiklar i publikationen
-
Journal of the A ...
- Av lärosätet
-
Uppsala universitet